vs
Esperion Therapeutics, Inc.（ESPR）与ONESPAWORLD HOLDINGS Ltd（OSW）财务数据对比。点击上方公司名可切换其他公司
ONESPAWORLD HOLDINGS Ltd的季度营收约是Esperion Therapeutics, Inc.的1.4倍（$242.1M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 11.5%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 7.1%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
ESPR vs OSW — 直观对比
营收规模更大
OSW
是对方的1.4倍
$168.4M
营收增速更快
ESPR
高出132.3%
11.5%
两年增速更快
ESPR
近两年复合增速
7.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $242.1M |
| 净利润 | — | $12.1M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | 6.8% |
| 净利率 | — | 5.0% |
| 营收同比 | 143.7% | 11.5% |
| 净利润同比 | — | -16.2% |
| 每股收益（稀释后） | $0.32 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPROSW
| Q4 25 | $168.4M | $242.1M | ||
| Q3 25 | $87.3M | $258.5M | ||
| Q2 25 | $82.4M | $240.7M | ||
| Q1 25 | $65.0M | $219.6M | ||
| Q4 24 | $69.1M | $217.2M | ||
| Q3 24 | $51.6M | $241.7M | ||
| Q2 24 | $73.8M | $224.9M | ||
| Q1 24 | $137.7M | $211.2M |
净利润ESPROSW
| Q4 25 | — | $12.1M | ||
| Q3 25 | $-31.3M | $24.3M | ||
| Q2 25 | $-12.7M | $19.9M | ||
| Q1 25 | $-40.5M | $15.3M | ||
| Q4 24 | — | $14.4M | ||
| Q3 24 | $-29.5M | $21.6M | ||
| Q2 24 | $-61.9M | $15.8M | ||
| Q1 24 | $61.0M | $21.2M |
营业利润率ESPROSW
| Q4 25 | 50.6% | 6.8% | ||
| Q3 25 | -11.4% | 10.2% | ||
| Q2 25 | 8.6% | 9.2% | ||
| Q1 25 | -34.0% | 7.7% | ||
| Q4 24 | -6.4% | 7.9% | ||
| Q3 24 | -31.0% | 10.3% | ||
| Q2 24 | 3.5% | 8.4% | ||
| Q1 24 | 52.5% | 8.0% |
净利率ESPROSW
| Q4 25 | — | 5.0% | ||
| Q3 25 | -35.9% | 9.4% | ||
| Q2 25 | -15.4% | 8.3% | ||
| Q1 25 | -62.2% | 7.0% | ||
| Q4 24 | — | 6.6% | ||
| Q3 24 | -57.2% | 8.9% | ||
| Q2 24 | -83.9% | 7.0% | ||
| Q1 24 | 44.3% | 10.0% |
每股收益（稀释后）ESPROSW
| Q4 25 | $0.32 | $0.12 | ||
| Q3 25 | $-0.16 | $0.23 | ||
| Q2 25 | $-0.06 | $0.19 | ||
| Q1 25 | $-0.21 | $0.15 | ||
| Q4 24 | $-0.14 | $0.13 | ||
| Q3 24 | $-0.15 | $0.20 | ||
| Q2 24 | $-0.33 | $0.15 | ||
| Q1 24 | $0.34 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $16.3M |
| 总债务越低越好 | — | $84.0M |
| 股东权益账面价值 | $-302.0M | $542.6M |
| 总资产 | $465.9M | $707.1M |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资ESPROSW
| Q4 25 | $167.9M | $16.3M | ||
| Q3 25 | $92.4M | $29.6M | ||
| Q2 25 | $86.1M | $35.0M | ||
| Q1 25 | $114.6M | $22.6M | ||
| Q4 24 | $144.8M | $57.4M | ||
| Q3 24 | $144.7M | $48.8M | ||
| Q2 24 | $189.3M | $62.5M | ||
| Q1 24 | $226.6M | $65.4M |
总债务ESPROSW
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $85.2M | ||
| Q2 25 | — | $96.2M | ||
| Q1 25 | — | $97.4M | ||
| Q4 24 | — | $98.6M | ||
| Q3 24 | — | $98.7M | ||
| Q2 24 | — | $123.8M | ||
| Q1 24 | — | $138.6M |
股东权益ESPROSW
| Q4 25 | $-302.0M | $542.6M | ||
| Q3 25 | $-451.4M | $552.8M | ||
| Q2 25 | $-433.5M | $548.3M | ||
| Q1 25 | $-426.2M | $530.6M | ||
| Q4 24 | $-388.7M | $554.5M | ||
| Q3 24 | $-370.2M | $540.1M | ||
| Q2 24 | $-344.2M | $532.7M | ||
| Q1 24 | $-294.3M | $515.5M |
总资产ESPROSW
| Q4 25 | $465.9M | $707.1M | ||
| Q3 25 | $364.0M | $732.6M | ||
| Q2 25 | $347.1M | $731.8M | ||
| Q1 25 | $324.0M | $708.7M | ||
| Q4 24 | $343.8M | $746.4M | ||
| Q3 24 | $314.1M | $734.0M | ||
| Q2 24 | $352.3M | $756.8M | ||
| Q1 24 | $373.1M | $763.6M |
负债/权益比ESPROSW
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $20.0M |
| 自由现金流经营现金流 - 资本支出 | — | $14.9M |
| 自由现金流率自由现金流/营收 | — | 6.2% |
| 资本支出强度资本支出/营收 | 0.0% | 2.1% |
| 现金转化率经营现金流/净利润 | — | 1.65× |
| 过去12个月自由现金流最近4个季度 | — | $68.4M |
8季度趋势，按日历期对齐
经营现金流ESPROSW
| Q4 25 | $45.2M | $20.0M | ||
| Q3 25 | $-4.3M | $33.2M | ||
| Q2 25 | $-31.4M | $20.3M | ||
| Q1 25 | $-22.6M | $10.1M | ||
| Q4 24 | $-35.0M | $16.6M | ||
| Q3 24 | $-35.3M | $28.6M | ||
| Q2 24 | $-7.2M | $18.7M | ||
| Q1 24 | $53.8M | $15.0M |
自由现金流ESPROSW
| Q4 25 | — | $14.9M | ||
| Q3 25 | — | $27.6M | ||
| Q2 25 | — | $17.6M | ||
| Q1 25 | — | $8.4M | ||
| Q4 24 | — | $13.2M | ||
| Q3 24 | $-35.5M | $27.5M | ||
| Q2 24 | $-7.3M | $17.6M | ||
| Q1 24 | $53.8M | $13.7M |
自由现金流率ESPROSW
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | — | 7.3% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | -68.7% | 11.4% | ||
| Q2 24 | -9.9% | 7.8% | ||
| Q1 24 | 39.0% | 6.5% |
资本支出强度ESPROSW
| Q4 25 | 0.0% | 2.1% | ||
| Q3 25 | 0.0% | 2.2% | ||
| Q2 25 | 0.0% | 1.1% | ||
| Q1 25 | 0.0% | 0.8% | ||
| Q4 24 | 0.0% | 1.5% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 0.1% | 0.6% |
现金转化率ESPROSW
| Q4 25 | — | 1.65× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 1.15× | ||
| Q3 24 | — | 1.33× | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | 0.88× | 0.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
